DrugPatentWatch Database Preview

DEPO-SUBQ PROVERA 104 Drug Profile

Email this page to a colleague

« Back to Dashboard

Which patents cover Depo-subq Provera 104, and what generic alternatives are available?

Depo-subq Provera 104 is a drug marketed by Pharmacia And Upjohn and is included in one NDA. There is one patent protecting this drug.

This drug has forty-three patent family members in twenty-nine countries.

The generic ingredient in DEPO-SUBQ PROVERA 104 is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Depo-subq Provera 104

A generic version of DEPO-SUBQ PROVERA 104 was approved as medroxyprogesterone acetate by BARR on August 9^th, 1996.

Summary for DEPO-SUBQ PROVERA 104

International Patents:	43
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	69
Clinical Trials:	51
Patent Applications:	4,422
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for DEPO-SUBQ PROVERA 104
DailyMed Link:	DEPO-SUBQ PROVERA 104 at DailyMed

Recent Clinical Trials for DEPO-SUBQ PROVERA 104

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
MU-JHU CARE	Phase 4
University of California, San Diego	Early Phase 1
Nationwide Children's Hospital	Phase 4

See all DEPO-SUBQ PROVERA 104 clinical trials

Recent Litigation for DEPO-SUBQ PROVERA 104

Identify potential future generic entrants

District Court Litigation

Case Name	Date
EAGLE PHARMACEUTICALS, INC. v. ACCORD HEALTHCARE, INC.	2019-03-27

See all DEPO-SUBQ PROVERA 104 litigation

Pharmacology for DEPO-SUBQ PROVERA 104

Drug Class

Progestin

Synonyms for DEPO-SUBQ PROVERA 104

(6-alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione

(6-alpha)-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-

(6?)-6-Methyl-3,20-dioxopregn-4-en-17-yl acetate

(6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-

(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione

(6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate

(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

010M483

16534-EP2269990A1

16534-EP2272517A1

16534-EP2275102A1

16534-EP2275413A1

16534-EP2281563A1

16534-EP2281815A1

16534-EP2287156A1

16534-EP2289893A1

16534-EP2289894A2

16534-EP2295550A2

16534-EP2298731A1

16534-EP2298743A1

16534-EP2298768A1

16534-EP2301933A1

16534-EP2305640A2

16534-EP2308861A1

16534-EP2311807A1

16534-EP2311827A1

16534-EP2314574A1

16534-EP2316459A1

17-Acetoxy-6-alpha-methylprogesterone

17-Acetoxy-6.alpha.-methylprogesterone

17-Acetoxy-6alpha-methylprogesterone

17-alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione

17-alpha-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione acetate

17-alpha-Hydroxy-6-alpha-methylprogesterone acetate

17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate

17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione

17.alpha.-Acetoxy-6.alpha.-methylprogesterone

17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate

17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate

17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate

17alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione

17alpha-Acetoxy-6alpha-methylprogesterone

17alpha-Hydroxy-6-alpha-methylprogesterone acetate

17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate

17alpha-Hydroxy-6alpha-methylprogesterone acetate

4-08-00-02212 (Beilstein Handbook Reference)

6-alpha-Methyl-17-acetoxy progesterone

6-alpha-Methyl-17-alpha-acetoxypregn-4-ene-3,20-dione

6-alpha-Methyl-17-alpha-acetoxyprogesterone

6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate

6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate

6-alpha-Methyl-4-pregnene-3,20-dion-17-alpha-ol acetate

6.alpha.-Methyl-17-acetoxyprogesterone

6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione

6.alpha.-Methyl-17.alpha.-acetoxyprogesterone

6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate

6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate

6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-

6alpha-Methyl-17-acetoxy progesterone

6alpha-Methyl-17-acetoxyprogesterone

6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione

6alpha-Methyl-17alpha-hydroxyprogesterone acetate

6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate

6alpha-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-

71-58-9

92480-EP2295416A2

92480-EP2295426A1

92480-EP2295427A1

92480-EP2298748A2

92480-EP2298768A1

92480-EP2305642A2

AB00384270_15

AB00384270-14

AB2000663

AC-2174

AI3-60127

AKOS015894870

Amen

Aragest

Aragest 5

AS-13981

BDBM50067678

BRN 2066112

C-21458

C08150

C2QI4IOI2G

CAS-71-58-9

CBP-1011

CC-30186

CCRIS 371

CHEBI:6716

CHEMBL717

Clinofem

Clinovir

CM0089

CPD000653524

CS-2583

Cycrin

Cykrina

D00951

DB00603

Depcorlutin

Depo-clinovir

Depo-Map

Depo-Medroxyprogesterone acetate

Depo-Prodasone

Depo-progestin

Depo-Progevera

Depo-Promone

Depo-Provera

Depo-provera (TN)

Depo-Provera Contraceptive

Depo-ProveraContraceptive

Depo-Ralovera

Depo-subq provera

Depo-subq provera 104 (TN)

Depocon

Depomedroxyprogesterone acetate

Deporone

Depot medroxyprogesterone acetate

Depot-medroxyprogesterone acetate

DP150

DSSTox_CID_5527

DSSTox_GSID_25527

DSSTox_RID_77819

DTXSID0025527

Dugen

EINECS 200-757-9

Farlutal

Farlutin

Gestapuran

HMS2233O07

HMS2235E05

HMS3259O14

HY-B0469

Hysron

I028

Indivina

KS-00001F8G

LS-1607

Lutopolar

Lutoral

MAP (steroid)

Med-Pro

Medrosterona

Medroxiprogesterone Acetate

Medroxyacetate progesterone

Medroxyprogesterone (acetate)

Medroxyprogesterone 17-acetate

Medroxyprogesterone 17-acetate, >=97% (HPLC)

Medroxyprogesterone 17-acetate, VETRANAL(TM), analytical standard

Medroxyprogesterone 17-acetate;MPA

Medroxyprogesterone acetate

Medroxyprogesterone acetate (JP17/USP)

Medroxyprogesterone acetate [JAN]

Medroxyprogesterone acetate [Progestins]

Medroxyprogesterone acetate [USP:JAN]

Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard

Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard

Medroxyprogesterone acetate, 97%

Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard

Medroxyprogesterone acetate, for performance test, European Pharmacopoeia (EP) Reference Standard

Medroxyprogesterone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material

Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard

Medroxyprogesterone-17-acetate

medroxyprogesterone-acetate

Medroxyprogesteroneacetate

Mepastat

Meprate

Methylacetoxyprogesterone

Metigestrona

MLS000069442

MLS001148217

MLS002207115

MPA GYM

MPA Hexal

MPA-beta

MPA-Noury

MRF-0000023

Nadigest

NC00574

NCGC00022037-03

NCGC00022037-04

NCGC00022037-05

NCGC00022037-07

NCGC00094713-01

NCGC00257695-01

NCGC00263480-01

Nidaxin

NSC 21171

NSC-21171

NSC-26386

NSC21171

NSC26386

ONCO-Provera

Opera_ID_1110

Oragest

P097000000

Perlutex

Perlutex Leo

Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, (6.alpha.)-

Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-, acetate

Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6a)-

Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-

Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate

Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate (8CI)

PREMPHASE (PREMARIN;CYCRIN 14/14)

Prempro

PREMPRO (PREMARIN;CYCRIN)

Prodasone

Progestalfa

Progesterone, 17-alpha-hydroxy-6-alpha-methyl-, acetate

Progesterone, 17-hydroxy-6alpha-methyl-, acetate

Progestins

Progevera

Promone-E

Provera

Provera (TN)

Provera dosepak

Proverone

PSGAAPLEWMOORI-PEINSRQWSA-N

PubChem13062

Q2823834

Ralovera

Repromap

Repromix

s2567

SAM002564220

SCHEMBL4276

Sirprogen

SMR000059125

SMR000653524

Sumiferm

Supprestral

Suprestral

Tox21_111319

Tox21_111319_1

Tox21_200141

TV-46046

U 8839

UNII-C2QI4IOI2G

Veramix

Veraplex

ZINC5029557

US Patents and Regulatory Information for DEPO-SUBQ PROVERA 104

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	DEPO-SUBQ PROVERA 104	medroxyprogesterone acetate	INJECTABLE;SUBCUTANEOUS	021583-001	Dec 17, 2004		RX	Yes	Yes			Y

Expired US Patents for DEPO-SUBQ PROVERA 104

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	DEPO-SUBQ PROVERA 104	medroxyprogesterone acetate	INJECTABLE;SUBCUTANEOUS	021583-001	Dec 17, 2004

International Patents for DEPO-SUBQ PROVERA 104

Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	007682
Estonia	05376
Hungary	0302021
South Korea	100828957
European Patent Office	1282402
Argentina	111695

Supplementary Protection Certificates for DEPO-SUBQ PROVERA 104

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0113964	97C0037	Belgium		PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826